IRLAB A — IRLAB Therapeutics AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for IRLAB Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	111	277	402	253	111
Net Total Accounts Receivable
Net Total Receivables	7.69	4.71	10.7	9.83	9.17
Prepaid Expenses
Total Other Current Assets
Total Current Assets	120	284	421	269	124
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.92	4.32	8.35	8.01	6.67
Net Intangible Assets
Other Long Term Assets
Total Assets	208	370	472	324	177
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23.3	20.9	69.4	32.3	36.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	26.2	22.2	73	32.7	61.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	182	348	399	291	116
Total Liabilities & Shareholders' Equity	208	370	472	324	177
Total Common Shares Outstanding